Zahlreiche Behandlungsoptionen sind in der Therapie des Melasmas untersucht, jedoch ist kein hiervon hundertprozentig wirksam. Alternative Therapieverfahren haben sich zu einer wichtigen Option der Medizin entwickelt.
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
Dr. Mathew Avram, has been elected President of the American Society for Laser Medicine and Surgery (ASLMS) for 2017. The election was by vote of the 4,000 members of the […]
– Net Sales +2.7%, benefiting from contribution of new businesses – Growth driven by Dermatology +13.3%, which now accounts for 43% of sales vs. 39% in Q1 15 – Product […]
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. More information: privacy statement and here.